Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02681965 · ClinicalTrials.gov registry record · NA

A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors

A NA study of Obesity and Breast Cancer Survivorship, sponsored by Yale University.

Completed
Registry status
NA
Development phase
205
Enrollment target
1
Study location

NCT02681965 is a NA study of Obesity and Breast Cancer Survivorship that has completed, run by Yale University. The registered enrollment target is 205 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02681965, a NA study of Obesity and Breast Cancer Survivorship, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
1
Study location

Study Summary

Proposed is a 6-month randomized controlled trial, in 200 overweight or obese Stage I-IIIC breast cancer survivors examining 6-month changes in: 1) body weight, 2) diet, 3) physical activity, and 4)quality of life in women randomized to receive the modified LEAN intervention compared to women randomized to wait-list control (i.e., the wait-list control will receive the modified LEAN intervention after completing the 6-month study).

Interventions

  • BEHAVIORAL LEAN book/videos

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2016-03
Est. Completion 2018-04-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT02681965

The ClinicalTrials.gov registry entry for NCT02681965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (75% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which LEAN book/videos is the first listed.

NCT02681965 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02681965 about?

NCT02681965 is a clinical study titled "A Mail and Video-based Weight Loss Trial in Breast Cancer Survivors". Proposed is a 6-month randomized controlled trial, in 200 overweight or obese Stage I-IIIC breast cancer survivors examining 6-month changes in: 1) body weight, 2) diet, 3) physical activity, and 4)quality of life in women randomized to receive the modified LEAN intervention compared to women random...

What is the current status of trial NCT02681965?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2016-03. Estimated completion is 2018-04-01.

What conditions does trial NCT02681965 study?

This clinical trial studies the following conditions: Obesity, Breast Cancer Survivorship.

What interventions are being tested in trial NCT02681965?

The interventions under investigation include: LEAN book/videos (BEHAVIORAL).

Who is sponsoring clinical trial NCT02681965?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02681965 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.